Myeloma UK together with expert haematologists and radiologists have jointly published new British Society of Haematology (BSH) guidelines for the use of imaging in the diagnosis and management of myeloma patients. This comes following the recent recommendations made by The International Myeloma Working Group (IMWG) and The National Institute for Health and Care Excellence (NICE) to incorporate imaging for defining myeloma and related conditions.These guidelines, published in the British Journal of Haematology, provide an evidence based approach for the use of cross-sectional modalities, including computer tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET), for the diagnosis and management of myeloma patients. They also demonstrates the applications of these imaging techniques for managing vertebral collapse and spinal cord compression, and assessing treatment response, relapse and solitary plasmacytoma.